2018Äê11ÔÂ16-17ÈÕ£¬£¬£¬£¬
£¬
£¬ÔÚƯÁÁµÄµÂ¹úÃÀÒòºÓÅÏ·¨À¼¿Ë¸£ÊУ¬£¬£¬£¬
£¬
£¬LAA CSI Focus 2018×óÐĶúרÌâ¾Û»áÊ¢´óÕÙ¿ª¡£¡£¡£¡£¡£À´×ÔÈ«Çò¸÷µØÐÄѪ¹Ü½éÈëÖÎÁÆÁìÓòµÄ¶¥¼âר¼Ò¹²¾Û·¨À¼¿Ë¸££¬£¬£¬£¬
£¬
£¬½»Á÷·ÖÏí×óÐĶú·â¶ÂÁìÓòµÄ×îÐÂÑо¿Ð§¹û¡£¡£¡£¡£¡£6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼¹«Ë¾ÒÀ¸½LAmbre?×óÐĶú·â¶ÂÆ÷ϵͳÓÅÒìµÄ²úÆ·Éè¼ÆºÍ׿ԽµÄÁÙ´²ÐÔÄÜ£¬£¬£¬£¬
£¬
£¬ÒÔ¼°ÔÚÅ·ÖÞºÍÖйúÉÏÊкó»ñµÃµÄÊг¡ÈÏ¿É£¬£¬£¬£¬
£¬
£¬ÔÙÒ»´ÎÔÚ¹ú¼Ê¸ß¶ËѧÊõ¾Û»áÉÏ´ó·ÅÒì²Ê¡£¡£¡£¡£¡£

11ÔÂ15ÈÕ£¬£¬£¬£¬
£¬
£¬´ó»á¿ªÄ»Ç°Ï¦£¬£¬£¬£¬
£¬
£¬6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼¹«Ë¾Ð­Í¬µÂ¹ú University Hospital Mainz Ò½ÔºÅäºÏ¾ÙÐÐÁËLAmbre? International Training Workshop£¬£¬£¬£¬
£¬
£¬WorkshopÓɵ¹úÖøÃû½á¹¹ÐÔÐÄÔಡר¼Ò½ÌÊÚStephan Von BardelebenΪÀ´×ÔÈðµä¡¢·¨¹ú¼°ÈÕ±¾µÄÒ½Éú¾ÙÐÐÁËLAmbre?µÄÊÖÊõ´ø½Ì£¬£¬£¬£¬
£¬
£¬ÎªÑ§Ô±ÃǾÙÐÐÁËÉîÈëdz³öµÄÊÖÊõ²Ù×÷½â˵£¬£¬£¬£¬
£¬
£¬ÈÃѧԱÃǶÔ×óÐĶú·â¶ÂÀú³ÌÒÔ¼°¶Ô6008¼¯ÍŹٷ½ÍøÕ¾LAmbre?×óÐĶú·â¶ÂÆ÷ϵͳµÄÓÅÔ½ÐÔÄÜÓÐÁËÔ½·¢Éî¿ÌºÍÖ±¹ÛµÄÊìϤ¡£¡£¡£¡£¡£

Stephan Von Bardeleben½ÌÊÚÓëѧԱºÏÓ°

11ÔÂ16ÈÕ£¬£¬£¬£¬
£¬
£¬ÓÉCSI ´ó»áÖ÷ϯ£¬£¬£¬£¬
£¬
£¬µÂÍõ·¨À¼¿Ë¸£ÐÄѪ¹ÜÖÐÐÄÖ÷ÈÎHorst Sievert½ÌÊÚÏò´ó»áÏÖ³¡Ö±²¥ÁËһ̨ѡÓÃ6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼LAmbre?×óÐĶú·â¶ÂÆ÷ϵͳ¾ÙÐеÄ×óÐĶú·â¶ÂÊÖÊõ¡£¡£¡£¡£¡£Horst Sievert½ÌÊÚ×ÛºÏÁË»¼Õß×óÐĶúµÄÆʽâ½á¹¹¼°Æ÷еµÄʹÓÃÇå¾²ÐÔ£¬£¬£¬£¬
£¬
£¬Ñ¡ÓÃÁË6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼LAmbre?×óÐĶú·â¶ÂÆ÷ϵͳ×÷ΪÊ×Ð㣬£¬£¬£¬
£¬
£¬ÊÖÊõºÜÊÇ˳Ë죬£¬£¬£¬
£¬
£¬¿ìËÙÍêÈ«·â¶Â¡£¡£¡£¡£¡£

11ÔÂ17Èյ¹úÍâµØʱ¼ä12µã10·Ö£¬£¬£¬£¬
£¬
£¬ÏÖ³¡Ö±²¥Á˵ڶþ̨ʹÓÃ6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼ÌØÊⶨÖƵÄСɡ´óÅÌLAmbre?×óÐĶú·â¶ÂÆ÷¾ÙÐеļ«ÆäÓÐÊýµÄ¸ßÄѶÈ×óÐĶú·â¶ÂÊõ¡£¡£¡£¡£¡£±¾ÀýÊÖÊõÓÉ·¨À¼¿Ë¸£ÐÄѪ¹ÜÖÐÐÄHorst Sievert½ÌÊÚÍŶÓÒÔ¼°Dr. Shakeel QureshiÅäºÏÍê³É¡£¡£¡£¡£¡£½ÓÊÜÊÖÊõµÄ»¼ÕßΪһÃû86ËêµÄÄÐÐÔ£¬£¬£¬£¬
£¬
£¬»¼ÓÐÌÇÄò²¡£¬£¬£¬£¬
£¬
£¬1986ÄêÖз磬£¬£¬£¬
£¬
£¬2018Äê1Ô·ºÆð²»Ã÷Ôµ¹ÊÔ­ÓÉÐÔÔÎØÊ¡£¡£¡£¡£¡£»£»£»£»£»£»¼Õß×óÊÒÉäѪ·ÖÊýÕý³££¬£¬£¬£¬
£¬
£¬¶þ¼â°ê£¬£¬£¬£¬
£¬
£¬Èý¼â°ê¹Ø±Õ²»È«£¬£¬£¬£¬
£¬
£¬CHA₂DS₂VAScÆÀ·Ö7·Ö£¬£¬£¬£¬
£¬
£¬HAS-BLEDÆÀ·Ö3·Ö£¬£¬£¬£¬
£¬
£¬Õï¶ÏΪһÁ¬ÐÔ·¿²ü¡£¡£¡£¡£¡£ÒòÆ仼ÓÐÅÁ½ðÉ­²¡£¬£¬£¬£¬
£¬
£¬Ë¤µ¹Î£º¦¸ß¶øÎÞ·¨¿Ú·þ¿¹ÄýÒ©£¬£¬£¬£¬
£¬
£¬ËìÑ¡Ôñ×óÐĶú·â¶ÂÊõ¡£¡£¡£¡£¡£¸Ã»¼Õß×óÐĶúÐÎ̬ÌØÊ⣬£¬£¬£¬
£¬
£¬×óÐĶúÐÎ״Ϊ¼¦³áÐÍ£¬£¬£¬£¬
£¬
£¬µ«È´Ê®·ÖdzÇÒ¶ú²¿Ö±½Ó±ÊÖ±ÓÚÆô³Ý´¦£¬£¬£¬£¬
£¬
£¬ÕÉÁ¿Ãª¶¨ÇøÖ±¾¶ÔÚ11.6mmµ½16.5mmÖ®¼ä£¬£¬£¬£¬
£¬
£¬Æô³Ý×î´óÖ±¾¶Îª25.9mm¡£¡£¡£¡£¡£´Ë²¡ÀýÔøÔÚ2018Äê6ÔÂTVT¾Û»áÉÏ×÷ΪÌØÊⲡÀý¾ÙÐÐlive case£¬£¬£¬£¬
£¬
£¬Íïϧ¾­¶à´ÎʵÑé²î±ð³§¼Ò¼°ÖÖÀàµÄ×óÐĶú·â¶ÂÆ÷¾ÙÐзâ¶Âºó¾ùÒÑʧ°ÜÁËÈ´¡£¡£¡£¡£¡£Horst Sievert½ÌÊÚ²¢Ã»Óоʹ˷ÅÆú£¬£¬£¬£¬
£¬
£¬ËûÏëµ½ÁË6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼£¬£¬£¬£¬
£¬
£¬6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼²»¸ºÖÚÍûÔÚ¶ÌÆÚÄÚΪ´Ë»¼Õ߶¨ÖÆÁËÈý¸öÌØÊâÐͺŵÄLAmbre?×óÐĶú·â¶ÂÆ÷À´¾ÈÖλ¼Õß¡£¡£¡£¡£¡£´Ë´ÎLive caseÊõÖÐ×îÖÕÑ¡ÓÃLT-LAA-1636ÐͺŵÄLAmbre?×óÐĶú·â¶ÂÆ÷¾ÙÐзâ¶Â£¬£¬£¬£¬
£¬
£¬·â¶ÂЧ¹ûÓÅÒì¡£¡£¡£¡£¡£»£»£»£»£»£»¼ÕßÖÕÓÚ»ñ»ñ¾ÈÖΣ¬£¬£¬£¬
£¬
£¬ÏÖ³¡±¬·¢³öһƬÈÈÁÒµÄÕÆÉù¡£¡£¡£¡£¡£

»¼ÕßÌØÊâ×óÐĶú½á¹¹ÕÉÁ¿Í¼

´ó»áÖ÷ϯHorst Sievert½ÌÊÚÔÚ¾ÙÐÐLAmbre?Ö²ÈëÊÖÊõ

6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼Îª»¼Õ߶¨ÖƵÄÌØÊâÐͺŵÄLAmbre?×óÐĶú·â¶ÂÆ÷Ö²ÈëÀÖ³É

Î人´óѧÈËÃñÒ½ÔºÐÄÄڿƻƺ׽ÌÊÚ, Dr. Apostolos Tzikas, Dr. Sameer Gafoor, Dr. Jacob OdenstedtÒÔ¼°Dr. Matthew Daniels¼¸Î»µãÆÀ¼Î±öÏÖ³¡ÀûÊÐÊõÖ±²¥¾ÙÐÐÁËÏêϸ»¥¶¯Ê½µÄÌÖÂÛ£¬£¬£¬£¬
£¬
£¬ÊÖÊõµÄÀֳɻñµÃÁËÔÚ³¡×¨¼ÒµÄ¸ß¶ÈÔÞÓþ¡£¡£¡£¡£¡£CSI´ó»áÒ²ÆÀ¼Û¸Ã²¡ÀýΪÓÐÊ·ÒÔÀ´×îÄѵÄ×óÐĶú·â¶ÂÊÖÊõ£¬£¬£¬£¬
£¬
£¬²î±ðµÄ³§¼Ò²úÆ·ÂÅÊÔÂŰܺ󣬣¬£¬£¬
£¬
£¬×îÖÕÓÉһö6008¼¯ÍŹٷ½ÍøÕ¾ÌØÖƵÄLAmbre?Àֳɷâ¶Â¡£¡£¡£¡£¡£

LAmbre?ÔÚ°ü¹ÜÇå¾²µÄͬʱ£¬£¬£¬£¬
£¬
£¬ÓÐן»ºñµÄÐͺÅÑ¡Ôñ£¬£¬£¬£¬
£¬
£¬¿ÉÒÔÓ¦¶Ô¶àÖÖÌØÊâµÄÐĶú½á¹¹£¬£¬£¬£¬
£¬
£¬Îª»¼Õß¼°Ò½ÉúÌṩÁËеÄÖÎÁÆÑ¡Ôñ¡£¡£¡£¡£¡£Ò»´ÎÓÖÒ»´ÎµÄÓ­½ÓÌôÕ½£¬£¬£¬£¬
£¬
£¬×ÊÖú»¼Õ߶ȹýÄѹØ¡£¡£¡£¡£¡£

ÁíÍ⣬£¬£¬£¬
£¬
£¬´Ë´ÎÊ¢»áÉÏÓжàλÀ´×ÔÖйúµÄ½á¹¹ÐÔÐÄÔಡר¼Ò¾ÙÐÐÁ˾«²ÊµÄѧÊõ±¨¸æ¡£¡£¡£¡£¡£Ê×ÏÈÓÉÀ´×ÔÖйúµÄÖ÷ϯÍųÉÔ±Î人´óѧÈËÃñÒ½ÔºÐÄÄڿƻƺ׽ÌÊÚΪ¸÷ÈË´øÀ´ÁËÌâΪ¡¶Öйú×óÐĶú·â¶ÂÊõµÄÏÖ×´ÓëÕ¹Íû¡·ºÍ¡¶×óÐĶúÌôÕ½²¡Àý·ÖÏí¡·µÄÁ½¸öÖ÷Ìâ½²»°£¬£¬£¬£¬
£¬
£¬ÏòÈ«Çòר¼Ò·ÖÏíÁËLAmbre?×óÐĶú·â¶ÂÆ÷ϵͳÔÚÖйú¸»ºñµÄÖ²ÈëÊý¾Ý¼°ÁÙ´²Ê¹ÓÃÂÄÀú¡£¡£¡£¡£¡£

Î人´óѧÈËÃñÒ½ÔºÐÄÄڿƻƺ׽ÌÊÚ½²»°ÏÖ³¡

À´×ÔÉϺ£ÊеÚÊ®ÈËÃñÒ½ÔºµÄÖìÃÎÔƽÌÊÚÓÃÁ÷ÀûµÄÓ¢ÎÄÏòÁÐλר¼Ò»ã±¨ÁËLAmbre?×óÐĶú·â¶ÂÆ÷µÄÌôÕ½²¡Àý£¬£¬£¬£¬
£¬
£¬²¢ÔÚÈ«ÇòÖڶಡÀýÖÐÍÑÓ±¶ø³ö£¬£¬£¬£¬
£¬
£¬»ñµÃÏÖ³¡×¨¼ÒµÄÒ»ÖºÃÆÀ£¬£¬£¬£¬
£¬
£¬ÈÙ»ñÁËÈ«³¡Î¨ÖðÒ»¸ö¡°×î¼Ñ²¡Àý½±¡±£¬£¬£¬£¬
£¬
£¬³ÉΪÖйúµÄ×ÔÂú¡£¡£¡£¡£¡£

ÖìÃÎÔƽÌÊÚ½µ£ÐĢչʾÁËÆäËùÔÚµÄÉϺ£ÊеÚÊ®ÈËÃñÒ½ÔºÐìÑÇΰ½ÌÊÚÍŶÓ

ÖìÃÎÔƽÌÊÚÈÙ»ñ×î¼Ñ²¡Àý½±£¬£¬£¬£¬
£¬
£¬ÓëÃÀ¹úÖøÃû½á¹¹ÐÄר¼ÒMaurice BuchbinderºÏÓ°

À´×ÔÖйúÏã¸ÛÂêÀöÒ½ÔºµÄ½á¹¹ÐÔÐÄÔಡר¼ÒDr. Simon LamΪ´ó»á´øÀ´ÁËÌâΪ¡¶When is LAA closure indicated according to guidelines Europe, US, Asia, worldwide¡·µÄ¾«²ÊÑݽ²¡£¡£¡£¡£¡£

À´×ÔÖйúÏã¸ÛµÄDr. Simon Lam¾ÙÐдó»á½²»°

±ðµÄ£¬£¬£¬£¬
£¬
£¬¶àλ¹ú¼Ê½á¹¹ÐÔÐÄÔಡר¼Ò¾ÙÐÐÁ˶à¸öÓйØLAmbre?×óÐĶú·â¶ÂÆ÷µÄ¾«²Ê±¨¸æ¡£¡£¡£¡£¡£À´×ÔÎ÷°àÑÀµÄ½á¹¹ÐÔÐÄÔಡר¼ÒXavier Freixa½ÒÏþÌâΪ¡¶Update on LAmbre? Trail¡·µÄ½²»°£¬£¬£¬£¬
£¬
£¬·ÖÏíÁËLISA ÊÔÑéµÄÉè¼ÆÀíÄ£¬£¬£¬
£¬
£¬ÆäÌåÏÖ£¬£¬£¬£¬
£¬
£¬ºóÆÚ½«»áÓÐÔ½À´Ô½¶àµÄÊÔÑéÖ¤¾Ý֤ʵLAmbre?×óÐĶú·â¶ÂÆ÷µÄÇå¾²ÐÔ¼°ÓÐÓÃÐÔ¡£¡£¡£¡£¡£

Î÷°àÑÀµÄXavier FreixaÒ½Éú½ÒÏþÌâΪ¡°Update on LAmbre?Trail¡±µÄ½²»°

À´×ÔÒâ´óÀûµÄÐÄÔàר¼ÒAchille Gaspardone½ÒÏþÌâΪ¡¶LAA closure in the presence of persistent thrombus: how to minimize the embolic risk¡·µÄ¾«²Ê½²»°£¬£¬£¬£¬
£¬
£¬·ÖÏíÁËÔõÑùÑ¡ÓÃÆ÷е¼°ÔõÑù²Ù×÷¿ÉÒÔ×èÖ¹Æ÷еÏà¹ØѪ˨,LAmbre? ×óÐĶú·â¶ÂÆ÷ÒòÆäÌØÊâµÄµª»¯îÑÍ¿²ã£¬£¬£¬£¬
£¬
£¬²¢ÇÒÊõÖÐÎÞÐèÉîÈë×óÐĶúµÄ²Ù×÷£¬£¬£¬£¬
£¬
£¬¿ÉÒÔ×îºéÁ÷ƽ½µµÍѪ˨¼°Ë¨ÈûµÄ±¬·¢¡£¡£¡£¡£¡£

Òâ´óÀûÐÄÔàר¼ÒAchille GasPardoneÔÚ»áÉÏ·ÖÏíÁËÆäʹÓÃLAmbre? ×óÐĶú·â¶ÂÆ÷µÄÊÖÊõ¼¼ÇÉ

Á½Î»À´×Ե¹úµÄ½á¹¹ÐÔÐÄÔಡר¼ÒDr. Norbert Klein¼° Dr. Leif-Hendrik Boldt»®·Ö´øÀ´ÌâΪ¡¶Complications of transseptal puncture: What can happen? How to prevent and how to manage¡·ºÍ¡¶Challenging cases with LAmbre?¡·µÄ¾«²Ê½²»°¡£¡£¡£¡£¡£¶à½Ç¶È»ã±¨ÁËLAmbre?×óÐĶú·â¶ÂÆ÷µÄ²úÆ·ÓÅÊÆ¡£¡£¡£¡£¡£

³ý´ËÖ®Í⣬£¬£¬£¬
£¬
£¬É½¶«Æë³ҽԺµÄÖÓ¾´Èª½ÌÊÚ×÷Ϊ´ó»áÖ÷³Ö¼Î±ö£¬£¬£¬£¬
£¬
£¬Óë¸÷¹úר¼ÒÅäºÏ¶ÔLAmbre?¾ÙÐÐÁ˾«²ÊµãÆÀ¼°ÂÄÀú·ÖÏí¡£¡£¡£¡£¡£

ÖÓ¾´Èª½ÌÊÚ£¨×óÒ»£©Óë¸÷¹úר¼Ò·ÖÏíÂÄÀú

¾Û»áʱ´ú£¬£¬£¬£¬
£¬
£¬6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼¹«Ë¾»¹¾ÙÐÐÁËÈ«ÇòÊðÀíÉÌÅàѵ£¬£¬£¬£¬
£¬
£¬Îª6008¼¯ÍŹٷ½ÍøÕ¾ÏàÖúͬ°é¾ÙÐÐÁËרҵһÁ¬µÄ²úƷ֪ʶ¡¢Êг¡¾ºÕùÇéÐÎÒÔ¼°¹«Ë¾Î´À´Éú³¤Õ½ÂÔµÈÏà¹ØÅàѵ£¬£¬£¬£¬
£¬
£¬ÖÂÁ¦ÓÚΪҽÉú»¼ÕßÌṩ×îרҵµÄЧÀÍ¡£¡£¡£¡£¡£

6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼¹ú¼ÊÓªÏúϵͳ¸±×ܲûÆÈô·ÉÏÈÉúΪÊðÀíÉ̾ÙÐÐÈ«Çò¾ºÕùÊг¡ÆÊÎö

6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼ÁÙ´²ÊÖÒÕר¼ÒNav SharmaŮʿ¾ÙÐÐ×óÐĶú·â¶ÂÆ÷²úƷ֪ʶÅàѵ

6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼Õ¹Ì¨Ó­À´ÖÚ¶àר¼ÒÂÃÐÐ

´ó»áÖ÷ϯHorst Sievert½ÌÊڸ߶ÈÔÞÓþ6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼LAmbre?×óÐĶú·â¶ÂÆ÷£¬£¬£¬£¬
£¬
£¬¶ÔÆä¼ÄÓèºñÍû

ÖøÃû½á¹¹ÐÔÐÄÔಡר¼ÒKavin Walsh½ÌÊÚÝ°ÁÙ6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼Õ¹Ì¨

11ÔÂ17ÈÕ£¬£¬£¬£¬
£¬
£¬¶ÌÔݶø¾«²ÊµÄLAA CSI Focus 2018Ê¢»áÂäÏÂá¡Ä»¡£¡£¡£¡£¡£Í¨¹ý´Ë´ÎÊ¢»á£¬£¬£¬£¬
£¬
£¬6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼ÕâÒ»ÁîÈË×ÔÂúµÄÃñ×åÆ·ÅÆÔٴγÉΪÁËÈ«ÌìÏÂÖõÄ¿µÄ½¹µã¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬
£¬
£¬6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼ÔÚ¹ú¼ÊÊг¡µÄÓ°ÏìÁ¦»ñµÃÁ˽øÒ»²½ÌáÉý£¬£¬£¬£¬
£¬
£¬Èú£ÄÚÍâÖÚ¶àÒ½ÉúºÍѧÕßÃǶÔÆäÁ¢Òì²úÆ·ºÍÁ¢ÒìʵÁ¦ÓÐÁËÔ½·¢Ö±¹ÛºÍÉîÈëµÄÊìϤ¡£¡£¡£¡£¡£Î´À´£¬£¬£¬£¬
£¬
£¬Ëæ×Å6008¼¯ÍŹٷ½ÍøÕ¾¿Æ¼¼Ô½À´Ô½¶àµÄÁ¢Òì²úÆ·»ñµÃ¹ú¼ÊÊг¡×¼È룬£¬£¬£¬
£¬
£¬½«»áÔ츣ȫÇò¸ü¶àµÄ»¼Õߣ¬£¬£¬£¬
£¬
£¬ÈÃÖйúÊÖÒÕ¸üºÃµÄЧÀÍÈ«Çò£¡